Barclays PLC Has $627,000 Stake in Enhabit, Inc. (NYSE:EHAB)

Barclays PLC decreased its stake in shares of Enhabit, Inc. (NYSE:EHAB) by 74.7% during the 3rd quarter, according to the company in its most recent filing with the SEC. The firm owned 79,321 shares of the company’s stock after selling 234,757 shares during the quarter. Barclays PLC owned 0.16% of Enhabit worth $627,000 as of its most recent filing with the SEC.

A number of other large investors have also made changes to their positions in EHAB. Geode Capital Management LLC raised its holdings in Enhabit by 0.9% in the 3rd quarter. Geode Capital Management LLC now owns 1,137,458 shares of the company’s stock valued at $8,987,000 after acquiring an additional 10,538 shares in the last quarter. Y Intercept Hong Kong Ltd bought a new stake in Enhabit in the 3rd quarter valued at $450,000. XTX Topco Ltd acquired a new position in shares of Enhabit in the 3rd quarter valued at $123,000. Zacks Investment Management bought a new position in shares of Enhabit during the 3rd quarter worth about $107,000. Finally, Jane Street Group LLC boosted its position in shares of Enhabit by 514.3% during the 3rd quarter. Jane Street Group LLC now owns 901,084 shares of the company’s stock valued at $7,119,000 after acquiring an additional 754,395 shares in the last quarter.

Analysts Set New Price Targets

EHAB has been the subject of a number of analyst reports. Jefferies Financial Group upgraded shares of Enhabit from a “hold” rating to a “buy” rating and raised their price target for the stock from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 price target (down previously from $8.50) on shares of Enhabit in a research note on Tuesday, November 19th. One research analyst has rated the stock with a sell rating, four have given a hold rating and one has given a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $8.75.

Insider Buying and Selling

In related news, Director Jeffrey Bolton purchased 4,000 shares of the stock in a transaction that occurred on Thursday, December 12th. The stock was acquired at an average price of $8.69 per share, with a total value of $34,760.00. Following the completion of the acquisition, the director now directly owns 98,144 shares in the company, valued at approximately $852,871.36. This trade represents a 4.25 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Stuart M. Mcguigan acquired 15,000 shares of the company’s stock in a transaction that occurred on Tuesday, December 10th. The stock was bought at an average price of $8.81 per share, with a total value of $132,150.00. Following the transaction, the director now directly owns 46,810 shares in the company, valued at $412,396.10. The trade was a 47.15 % increase in their ownership of the stock. The disclosure for this purchase can be found here. 1.90% of the stock is owned by corporate insiders.

Enhabit Stock Performance

NYSE EHAB opened at $7.98 on Friday. Enhabit, Inc. has a 1-year low of $6.85 and a 1-year high of $11.74. The company has a 50 day moving average of $7.82 and a 200-day moving average of $8.12. The company has a current ratio of 1.46, a quick ratio of 1.46 and a debt-to-equity ratio of 0.85. The firm has a market cap of $401.39 million, a price-to-earnings ratio of -3.44 and a beta of 1.82.

Enhabit (NYSE:EHAB) last issued its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). The business had revenue of $253.60 million during the quarter, compared to the consensus estimate of $261.69 million. Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. During the same quarter in the previous year, the firm posted $0.03 EPS. On average, equities analysts forecast that Enhabit, Inc. will post 0.22 earnings per share for the current fiscal year.

Enhabit Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.